Concepedia
Statistics
Publications
154
Citations
9.1K
H-Index
48
Active since
1990
Affiliations
National Cancer Institute(Current)
Center for Cancer Research
Kanion Pharmaceutical (China)
National Institutes of Health
University of Hong Kong
Liang Cao is an author at National Cancer Institute specializing in medicine, pharmacology, and immunology.
Top concepts
MedicinePharmacologyImmunologyCell BiologyInflammationPathologyTumor BiologyCell SignalingOncologyCancer Research
Publications per year
1990–2024
A pathway for generation and processing of double-strand breaks during meiotic recombination in S. cerevisiae
Liang Cao, Eric Alani, Nancy Kleckner · Cell · 1990 · 684 citations
Chromatin, Genome Instability, Cell Division +12
Temporal comparison of recombination and synaptonemal complex formation during meiosis in S. cerevisiae
Ruth Padmore, Liang Cao, Nancy Kleckner · Cell · 1991 · 451 citations
Temporal Comparison, Chromatin, Synaptonemal Complex Formation +13
Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors
Julius Strauss, Christopher R. Heery, Jeffrey Schlom et al. · Clinical Cancer Research · 2018 · 406 citations · Full text
Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F
Liang Cao, Barbara Faha, Marlene Dembski et al. · Nature · 1992 · 374 citations
Transcriptional Regulation, Signaling Pathway, Cell Regulation +13
Combination Targeted Therapy With Sorafenib and Bevacizumab Results in Enhanced Toxicity and Antitumor Activity
Nilofer S. Azad, Edwin M. Posadas, Virginia E. Kwitkowski et al. · Journal of Clinical Oncology · 2008 · 336 citations · Full text
1–5 of 154